1.50
price down icon9.09%   -0.15
after-market Dopo l'orario di chiusura: 1.50
loading

Alx Oncology Holdings Inc Azioni (ALXO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
16.25%
26.65
31.82 30.61 32.57 41.52
Interest Income/Expense
0.25%
0.405
0.406 0.427 0.446 0.429
Depreciation and Amortization
0.00%
0.20
0.20 0.20 0.20 0.20
Operating Income/Loss
16.25%
-26.65
-31.82 -30.61 -32.57 -41.52
Income/Loss From Continuing Operations Before Tax
15.62%
-25.95
-30.75 -29.16 -30.71 -39.40
Income/Loss From Continuing Operations After Tax
15.62%
-25.95
-30.75 -29.16 -30.71 -39.40
Net Income/Loss
15.62%
-25.95
-30.75 -29.16 -30.71 -39.40
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.16%
53.45
53.36 0.6304 52.69 51.83
Diluted Average Shares
0.16%
53.45
53.36 0.6304 52.69 51.83
Basic Earnings Per Share
15.52%
-0.49
-0.58 -0.53 -0.58 -0.76
Diluted Earnings Per Share
15.52%
-0.49
-0.58 -0.53 -0.58 -0.76
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):